Tavitian, Suzanne <br/><br/>
Impact of obesity in favorable-risk AML patients receiving intensive chemotherapy.  [electronic resource] 

 -  American journal of hematology  Feb 2016 
 - 193-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.24228  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Body Mass Index<br/>Body Surface Area<br/>Disease-Free Survival<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Induction Chemotherapy<br/>Leukemia, Myeloid, Acute--complications<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Obesity--complications<br/>Retrospective Studies<br/>Risk<br/>Treatment Outcome